Overview

Intravenous Lidocaine in Bariatric Surgery.

Status:
Unknown status

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

Although peroperative intravenous lidocaine has been shown to be useful in early recovery after colorectal surgery, its beneficial effect on the specific population of obese patients scheduled for bariatric surgery remained unknown. Investigators hypothesized that peroperative intravenous lidocaine could decrease postoperative opioid consumption and improve postoperative recovery

Phase:

Phase 3

Details

Lead Sponsor:

University Hospital, Caen

Treatments:

Lidocaine